TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 1 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $207,000 | 0.0% | 154,782 | -15.6% | 0.00% | – |
| Q4 2018 | $207,000 | -43.1% | 183,337 | +217.7% | 0.00% | – |
| Q4 2017 | $364,000 | -67.4% | 57,715 | -64.6% | 0.00% | -100.0% |
| Q3 2017 | $1,117,000 | +620.6% | 163,266 | +650.1% | 0.00% | – |
| Q2 2017 | $155,000 | +287.5% | 21,766 | +110.6% | 0.00% | – |
| Q3 2016 | $40,000 | -73.2% | 10,334 | -70.2% | 0.00% | – |
| Q2 2016 | $149,000 | -29.0% | 34,732 | -23.3% | 0.00% | – |
| Q1 2016 | $210,000 | -77.0% | 45,279 | -63.1% | 0.00% | -100.0% |
| Q3 2015 | $914,000 | -85.0% | 122,545 | -4.6% | 0.00% | -83.3% |
| Q2 2015 | $6,095,000 | +73.6% | 128,462 | +34.1% | 0.01% | +50.0% |
| Q1 2015 | $3,510,000 | +199.7% | 95,800 | +224.7% | 0.01% | +300.0% |
| Q4 2014 | $1,171,000 | +302.4% | 29,500 | +102.1% | 0.00% | +100.0% |
| Q3 2014 | $291,000 | +47.7% | 14,600 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $197,000 | – | 14,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 317,900 | $11,647,000 | 4.28% |
| Opaleye Management Inc. | 175,000 | $6,412,000 | 2.98% |
| Graticule Asia Macro Advisors LLC | 413,200 | $15,139,000 | 2.02% |
| BB BIOTECH AG | 1,477,114 | $54,121,000 | 1.61% |
| Iguana Healthcare Management, LLC | 75,000 | $2,748,000 | 1.16% |
| Granite Point Capital Management, L.P. | 79,250 | $2,904,000 | 1.06% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 458,202 | $16,788,000 | 0.89% |
| Ghost Tree Capital, LLC | 130,000 | $4,764,000 | 0.86% |
| SECTORAL ASSET MANAGEMENT INC | 605,393 | $22,182,000 | 0.84% |
| HealthCor Management, L.P. | 467,200 | $17,118,000 | 0.82% |